Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2002 3
2003 3
2004 3
2005 3
2006 2
2007 5
2008 4
2009 4
2010 10
2011 7
2012 4
2013 11
2014 4
2015 2
2016 5
2017 7
2018 10
2019 2
2020 6
2021 10
2022 1
2023 10
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

107 results

Results by year

Filters applied: . Clear all
Page 1
Nutritional and metabolic factors in amyotrophic lateral sclerosis.
Ludolph A, Dupuis L, Kasarskis E, Steyn F, Ngo S, McDermott C. Ludolph A, et al. Among authors: dupuis l. Nat Rev Neurol. 2023 Sep;19(9):511-524. doi: 10.1038/s41582-023-00845-8. Epub 2023 Jul 27. Nat Rev Neurol. 2023. PMID: 37500993 Review.
Amyotrophic lateral sclerosis (ALS) is a complex neurodegenerative disease that is classically thought to impact the motor system. ...
Amyotrophic lateral sclerosis (ALS) is a complex neurodegenerative disease that is classically thought to impact the mo
Skeletal muscle in amyotrophic lateral sclerosis.
Shefner JM, Musaro A, Ngo ST, Lunetta C, Steyn FJ, Robitaille R, De Carvalho M, Rutkove S, Ludolph AC, Dupuis L. Shefner JM, et al. Among authors: dupuis l. Brain. 2023 Nov 2;146(11):4425-4436. doi: 10.1093/brain/awad202. Brain. 2023. PMID: 37327376 Free PMC article. Review.
Amyotrophic lateral sclerosis (ALS), the major adult-onset motor neuron disease, has been viewed almost exclusively as a disease of upper and lower motor neurons, with muscle changes interpreted as a consequence of the progressive loss of motor neurons and ne
Amyotrophic lateral sclerosis (ALS), the major adult-onset motor neuron disease, has been viewed almost exclusively as
Integrative genetic analysis illuminates ALS heritability and identifies risk genes.
Megat S, Mora N, Sanogo J, Roman O, Catanese A, Alami NO, Freischmidt A, Mingaj X, De Calbiac H, Muratet F, Dirrig-Grosch S, Dieterle S, Van Bakel N, Müller K, Sieverding K, Weishaupt J, Andersen PM, Weber M, Neuwirth C, Margelisch M, Sommacal A, Van Eijk KR, Veldink JH; Project Mine Als Sequencing Consortium; Lautrette G, Couratier P, Camuzat A, Le Ber I, Grassano M, Chio A, Boeckers T, Ludolph AC, Roselli F, Yilmazer-Hanke D, Millecamps S, Kabashi E, Storkebaum E, Sellier C, Dupuis L. Megat S, et al. Among authors: dupuis l. Nat Commun. 2023 Jan 20;14(1):342. doi: 10.1038/s41467-022-35724-1. Nat Commun. 2023. PMID: 36670122 Free PMC article.
Amyotrophic lateral sclerosis (ALS) has substantial heritability, in part shared with fronto-temporal dementia (FTD). ...
Amyotrophic lateral sclerosis (ALS) has substantial heritability, in part shared with fronto-temporal dementia (FTD). .
Hypothalamus and weight loss in amyotrophic lateral sclerosis.
Ahmed RM, Steyn F, Dupuis L. Ahmed RM, et al. Among authors: dupuis l. Handb Clin Neurol. 2021;180:327-338. doi: 10.1016/B978-0-12-820107-7.00020-3. Handb Clin Neurol. 2021. PMID: 34225938 Review.
Amyotrophic lateral sclerosis (ALS) is a devastating progressive neurodegenerative disorder. ...
Amyotrophic lateral sclerosis (ALS) is a devastating progressive neurodegenerative disorder. ...
Paradox of amyotrophic lateral sclerosis and energy metabolism.
Ahmed RM, Dupuis L, Kiernan MC. Ahmed RM, et al. Among authors: dupuis l. J Neurol Neurosurg Psychiatry. 2018 Oct;89(10):1013-1014. doi: 10.1136/jnnp-2018-318428. Epub 2018 May 7. J Neurol Neurosurg Psychiatry. 2018. PMID: 29735514 No abstract available.
Thermoregulation in amyotrophic lateral sclerosis.
Dupuis L, Petersen Å, Weydt P. Dupuis L, et al. Handb Clin Neurol. 2018;157:749-760. doi: 10.1016/B978-0-444-64074-1.00046-X. Handb Clin Neurol. 2018. PMID: 30459038 Review.
Amyotrophic lateral sclerosis (ALS) is the major adult-onset motor neuron disease, and is clinically, pathologically, and genetically associated with frontotemporal dementia, the second cause of dementia in the elderly. ...
Amyotrophic lateral sclerosis (ALS) is the major adult-onset motor neuron disease, and is clinically, pathologically, a
Cortical hyperexcitability in mouse models and patients with amyotrophic lateral sclerosis is linked to noradrenaline deficiency.
Scekic-Zahirovic J, Benetton C, Brunet A, Ye X, Logunov E, Douchamps V, Megat S, Andry V, Kan VWY, Stuart-Lopez G, Gilet J, Guillot SJ, Dirrig-Grosch S, Gorin C, Trombini M, Dieterle S, Sinniger J, Fischer M, René F, Gunes Z, Kessler P, Dupuis L, Pradat PF, Goumon Y, Goutagny R, Marchand-Pauvert V, Liebscher S, Rouaux C. Scekic-Zahirovic J, et al. Among authors: dupuis l. Sci Transl Med. 2024 Mar 13;16(738):eadg3665. doi: 10.1126/scitranslmed.adg3665. Epub 2024 Mar 13. Sci Transl Med. 2024. PMID: 38478631
Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease, characterized by the death of upper (UMN) and lower motor neurons (LMN) in the motor cortex, brainstem, and spinal cord. ...
Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease, characterized by the death of upper (UM
Comparison of spinal magnetic resonance imaging and classical clinical factors in predicting motor capacity in amyotrophic lateral sclerosis.
Khamaysa M, Lefort M, Pélégrini-Issac M, Lackmy-Vallée A, Preuilh A, Devos D, Rolland AS, Desnuelle C, Chupin M, Marchand-Pauvert V, Querin G, Pradat PF; Pulse study group. Khamaysa M, et al. J Neurol. 2023 Aug;270(8):3885-3895. doi: 10.1007/s00415-023-11727-w. Epub 2023 Apr 27. J Neurol. 2023. PMID: 37103756
BACKGROUND: Motor capacity is crucial in amyotrophic lateral sclerosis (ALS) clinical trial design and patient care. ...Multiple stepwise linear regression models were constructed to predict motor capacity at 3 and 6 months from diagnosis, based on clinical v …
BACKGROUND: Motor capacity is crucial in amyotrophic lateral sclerosis (ALS) clinical trial design and patient care. .. …
Mechanisms, models and biomarkers in amyotrophic lateral sclerosis.
Turner MR, Bowser R, Bruijn L, Dupuis L, Ludolph A, McGrath M, Manfredi G, Maragakis N, Miller RG, Pullman SL, Rutkove SB, Shaw PJ, Shefner J, Fischbeck KH. Turner MR, et al. Among authors: dupuis l. Amyotroph Lateral Scler Frontotemporal Degener. 2013 May;14 Suppl 1(0 1):19-32. doi: 10.3109/21678421.2013.778554. Amyotroph Lateral Scler Frontotemporal Degener. 2013. PMID: 23678877 Free PMC article. Review.
The last 30 years have seen a major advance in the understanding of the clinical and pathological heterogeneity of amyotrophic lateral sclerosis (ALS), and its overlap with frontotemporal dementia. ...
The last 30 years have seen a major advance in the understanding of the clinical and pathological heterogeneity of amyotrophic lat
Oligodendrocytes in amyotrophic lateral sclerosis and frontotemporal dementia: the new players on stage.
Jamet M, Dupuis L, Gonzalez De Aguilar JL. Jamet M, et al. Among authors: dupuis l. Front Mol Neurosci. 2024 Mar 22;17:1375330. doi: 10.3389/fnmol.2024.1375330. eCollection 2024. Front Mol Neurosci. 2024. PMID: 38585368 Free PMC article. Review.
Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are fatal adult-onset neurodegenerative disorders that share clinical, neuropathological and genetic features, which forms part of a multi-system disease spectrum. ...
Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are fatal adult-onset neurodegenerative disorders
107 results